A team students from National Yang Ming University (NYMU) students have won a gold medal at the International Genetic Engineering Machine 2007 (iGEM 2007) competition.
Their project could help diabetics improve their quality of life and was titled "GlucOperon: An auto-regulated system with both feed-forward and feed-back controls."
The team was made up of seven undergraduate students from the Department of Life Sciences, Department of Medicine and Department of Dentistry, plus five graduate students from the Institute of Bioinformatics and Institute of Biotechnology in Medicine, university sources said.
The iGEM award is an initiative of the Massachusetts Institute of Technology (MIT) iCampus program. The objective of the annual competition is to provide a platform for teams of students worldwide to design and build engineered biological systems using advanced genetic components and technologies.
Since its launch, the iGEM award has become a popular annual competition among university students around the world. This year, the contest drew 59 teams and 580 students from 18 different countries.
The NYMU team, the sole representatives from Taiwan, said its GlucOperon project was the result of team brainstorming.
The team used Escherichia coli (E. coli) as a model to assess the feasibility of the whole insulin secretion system. If the system can successfully be applied to human bodies, it could help diabetic patients avoid stroke caused by insulin overdose.
The project focuses on the development of a prokaryotic system to reduce the reliance of patients on synthetic insulin. The concept was widely praised by participating teams for its innovation and feasibility, the sources said.
In addition to the NYMU team, teams from US-based Harvard University, Princeton University and University of California, Berkeley, also won gold medals in the competition, the sources said.
CLASSES HALTED: Cram schools have had to return tuition fees due to mandatory closures and might need to lay off half of their staff because of a lack of revenue The COVID-19 pandemic has taken a toll on the education sector, with some cram schools and tutoring centers saying they might soon be unable to pay their instructors due to the extension of a nationwide level 3 COVID-19 alert. The heightened alert level means schools must remain closed, so cram schools and tutoring centers have had to return tuition fees, one cram school said. June is normally the peak season for recruiting new students at cram schools and tutoring centers, but this year many such schools might need to lay off half of their staff due to a lack of
A student at National Chengchi University jumped from the roof of his apartment in the early hours of Sunday after he was allegedly bullied online. The 21-year-old student, surnamed Huang (黃), on Friday last week posted on the university’s online discussion forum asking the public to judge a dispute he was having with a female roommate about rent. An anonymous post on the online forum Dcard appeared on the same day, saying he was the last person to judge others, and that he was “a heavy smoker, lazy, a terrible group member for class projects and a person with a poor
While the antiparasitic drug ivermectin is being touted as a treatment for COVID-19 in many parts of the world, Taiwanese experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence. “Following an experts’ meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to the lack of enough evidence,” said Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center’s (CECC) expert advisory panel. A report in the American Journal of Therapeutics said that meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 patients had found large,
A person who was on Friday reported as the first in Taiwan to die after receiving a COVID-19 vaccine died of a heart attack, a Central Epidemic Command Center (CECC) official said yesterday. The deceased, whose sex and age were not disclosed, had coronary artery disease, which led to a fatal heart attack, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, told a news conference, citing the autopsy report. It was the first death listed as a possible adverse event after receiving the AstraZenenca COVID-19 vaccine since the start of the vaccination program on March 22. The